IL22 and neoplasm: Higher T regs and lower CD8+ T cells, which result in decreased immune surveillance, and increased exposure to IL-22, which enhances tumor proliferation, represent two main factors that contribute to the aggressive nature of TSCC (101) (Figure 4).